171 results
Page 5 of 9
424B5
9vpwaypk
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-1.1
f6ny 2clf3zp7n2f
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
ztg9s 8u4nxr9v2ef3e
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
29mz 101pc42h81fgn
14 Jan 20
Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
6:17am
8-K
EX-10.1
i2h611lg4a0iooj
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
fyi to384z7
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
S-8
EX-23.1
r2axpw vhxyj
30 Aug 19
Registration of securities for employees
12:30pm
8-K
EX-10.1
2v901f
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-10.1
jgkn mfrzh
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-99.1
0hgrht9p2eop0
25 Jul 19
Other Events
8:07am
8-K
EX-10.1
ahec3 iw24nbty1ap
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.2
dscc lmde5ys
27 Jun 19
Departure of Directors or Certain Officers
8:08am